[go: up one dir, main page]

MXPA01008148A - Derivados de epotilona, metodo para su produccion y su uso farmaceutico. - Google Patents

Derivados de epotilona, metodo para su produccion y su uso farmaceutico.

Info

Publication number
MXPA01008148A
MXPA01008148A MXPA01008148A MXPA01008148A MXPA01008148A MX PA01008148 A MXPA01008148 A MX PA01008148A MX PA01008148 A MXPA01008148 A MX PA01008148A MX PA01008148 A MXPA01008148 A MX PA01008148A MX PA01008148 A MXPA01008148 A MX PA01008148A
Authority
MX
Mexico
Prior art keywords
pharmaceuticals
production
epothilon
derivatives
epothilon derivatives
Prior art date
Application number
MXPA01008148A
Other languages
English (en)
Inventor
Ulrich Klar
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999107480 external-priority patent/DE19907480A1/de
Priority claimed from DE19954229A external-priority patent/DE19954229A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of MXPA01008148A publication Critical patent/MXPA01008148A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MXPA01008148A 1999-02-11 2000-02-11 Derivados de epotilona, metodo para su produccion y su uso farmaceutico. MXPA01008148A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999107480 DE19907480A1 (de) 1999-02-11 1999-02-11 Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE19954229A DE19954229A1 (de) 1999-11-04 1999-11-04 Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
PCT/EP2000/001104 WO2000047584A2 (de) 1999-02-11 2000-02-11 Epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
MXPA01008148A true MXPA01008148A (es) 2003-07-21

Family

ID=26051977

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01008148A MXPA01008148A (es) 1999-02-11 2000-02-11 Derivados de epotilona, metodo para su produccion y su uso farmaceutico.

Country Status (21)

Country Link
US (2) US7001916B1 (es)
EP (1) EP1161430A2 (es)
JP (1) JP2002536450A (es)
KR (1) KR20010094763A (es)
CN (1) CN1340053A (es)
AU (1) AU4101800A (es)
BG (1) BG105803A (es)
BR (1) BR0008206A (es)
CA (1) CA2360952A1 (es)
CZ (1) CZ20012886A3 (es)
EA (1) EA200100833A1 (es)
EE (1) EE200100422A (es)
HK (1) HK1044946A1 (es)
HU (1) HUP0105330A2 (es)
IL (1) IL144370A0 (es)
MX (1) MXPA01008148A (es)
NO (1) NO20013900L (es)
PL (1) PL350190A1 (es)
SK (1) SK11452001A3 (es)
WO (1) WO2000047584A2 (es)
YU (1) YU57601A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734362T2 (de) 1996-12-03 2006-07-20 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6660758B1 (en) * 1996-12-13 2003-12-09 The Scripps Research Institute Epothilone analogs
US7125893B1 (en) * 1999-04-30 2006-10-24 Schering Ag 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
CA2439268C (en) * 2001-02-27 2010-01-19 Novartis Ag Combination comprising a signal transduction inhibitor and an epothilone derivative
WO2003018002A2 (en) * 2001-08-23 2003-03-06 Novartis Ag Cyclopropyl and cyclobutyl epothilone analogs
AU2003218110A1 (en) 2002-03-12 2003-09-29 Bristol-Myers Squibb Company C3-cyano epothilone derivatives
AU2003242646A1 (en) * 2002-06-10 2003-12-22 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
RU2379032C9 (ru) * 2002-06-10 2010-03-27 Новартис Аг Комбинации, включающие эпотилоны, и их фармацевтическое применение
RU2338741C2 (ru) * 2002-07-31 2008-11-20 Мершан Корпорейшн Новые физиологически активные вещества
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP1589011A1 (en) * 2004-04-22 2005-10-26 Schering Aktiengesellschaft Novel chiral heptyne derivates for the preparation of epothilones and processes for their preparation
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
US20100113128A1 (en) * 2008-11-05 2010-05-06 Snow Richard N Methods and apparatus for determining a reel strip position
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
US20100125146A1 (en) * 2008-11-19 2010-05-20 Johnson Matthey Public Limited Company Method for making pharmaceutical compounds
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
CN108430996A (zh) * 2015-10-16 2018-08-21 威廉马歇莱思大学 埃博霉素类似物、合成方法、治疗方法及其药物缀合物
WO2017096559A1 (en) * 2015-12-09 2017-06-15 Rhodia Operations Production of xylene derivatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
US5469145A (en) 1992-05-29 1995-11-21 Johnson; Lonnie Wet diaper detector
EP1186606B2 (de) 1995-11-17 2011-09-07 Gesellschaft für Biotechnologische Forschung mbH (GBF) Epothilon-Derivate, ihre Herstellung und Verwendung
US6441025B2 (en) 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US5969145A (en) 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
AU716610B2 (en) 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
DE19636343C1 (de) 1996-08-30 1997-10-23 Schering Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
US6867305B2 (en) * 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DE69734362T2 (de) 1996-12-03 2006-07-20 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
DE19701758A1 (de) 1997-01-20 1998-07-23 Wessjohann Ludgar A Dr Epothilone-Synthesebausteine
US6605599B1 (en) * 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
AU9340998A (en) * 1997-08-09 1999-03-01 Schering Aktiengesellschaft New epothilone derivatives, method for producing same and their pharmaceutical use
AU4775299A (en) * 1998-06-22 2000-01-10 Nicolaou, Kyriacos Costa Desmethyl epothilones
AU6208701A (en) 2000-03-09 2001-09-17 Schering Aktiengesellschaft Radioactively labeled epothilone derivatives, method for the production thereof, and their biochemical and pharmaceutical use
CA2359267A1 (en) 2000-10-19 2002-04-19 Manabu Takami Wavelength selecting module and wavelength selecting apparatus
EP1340498A1 (en) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Use of epothilones in the treatment of brain diseases associated with proliferative processes
KR20050026033A (ko) * 2002-07-31 2005-03-14 쉐링 악티엔게젤샤프트 신규 효과기 접합체, 그의 제조 방법 및 그의 약학적 용도
AU2003256417A1 (en) 2002-08-13 2004-02-25 Kosan Biosciences, Inc. Transposon-based transformation system

Also Published As

Publication number Publication date
CZ20012886A3 (cs) 2001-11-14
YU57601A (sh) 2005-06-10
NO20013900D0 (no) 2001-08-10
SK11452001A3 (sk) 2002-04-04
NO20013900L (no) 2001-10-11
KR20010094763A (ko) 2001-11-01
HK1044946A1 (zh) 2002-11-08
EP1161430A2 (de) 2001-12-12
EA200100833A1 (ru) 2002-02-28
PL350190A1 (en) 2002-11-18
EE200100422A (et) 2002-12-16
BR0008206A (pt) 2002-02-19
BG105803A (en) 2002-03-29
CA2360952A1 (en) 2000-08-17
HUP0105330A2 (hu) 2002-05-29
IL144370A0 (en) 2002-05-23
CN1340053A (zh) 2002-03-13
WO2000047584A2 (de) 2000-08-17
US7001916B1 (en) 2006-02-21
AU4101800A (en) 2000-08-29
US20060040990A1 (en) 2006-02-23
JP2002536450A (ja) 2002-10-29
WO2000047584A3 (de) 2000-12-28

Similar Documents

Publication Publication Date Title
ZA200104196B (en) Azepinoindole derivatives, the production and use thereof.
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
HUS1400005I1 (hu) Kinazolinszármazékok, elõállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerek
IL146105A0 (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use thereof
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
MXPA01008148A (es) Derivados de epotilona, metodo para su produccion y su uso farmaceutico.
MXPA03000873A (es) Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
AU3162001A (en) Medicament, a method for its production and the use thereof
MXPA03008630A (es) Derivados de arilisoxazolinas, procedimientos para su preparacion y su utilizacion como agentes plaguicidas.
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
AU7961200A (en) Urea derivative, process for producing the same, and medicine containing the urea derivative
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
PL354192A1 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
ZA200407361B (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof.
HUP0200928A3 (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
IL145041A (en) Morpholine derivatives, methods for the production thereof and pharmaceutical preparations
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
ZA200103191B (en) Vancoresmycin, a process for its production and its use as a pharmaceutical.
HU0001397D0 (en) 3-amino-3-arylpropan-1-ol derivatives, production and use thereof
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
AU7517800A (en) 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
MXPA03004632A (es) Klainetina y sus derivados, metodo para su produccion y su uso.
AU2155901A (en) Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments